Utmost Group files Schedule 13G disclosing TLSI stake of 2.0M shares
Rhea-AI Filing Summary
Utmost Group PLC reports beneficial ownership of 2,000,588 shares of TriSalus Life Sciences Inc. common stock, representing 0.0529% of the outstanding class. The filing states Utmost has sole voting and dispositive power over all reported shares and identifies Lombard International Assurance SA as a subsidiary acquired by Utmost on 30/12/2024. The disclosure explains the percentage ownership fell because TriSalus’ total outstanding shares increased to 37,838,962. The filing is a Schedule 13G indicating passive reporting under the Exchange Act rules and includes Utmost’s UK address and an authorized signature by the Group CFO dated 08/11/2025.
Positive
- Clear disclosure of beneficial ownership: 2,000,588 shares with sole voting and dispositive power
- Compliance with reporting rules via Schedule 13G and identification of subsidiary (Lombard International Assurance SA)
Negative
- De minimis economic/ownership impact: stake represents only 0.0529% of the class
- Dilution noted: percentage ownership fell because outstanding shares increased to 37,838,962
Insights
TL;DR: Small passive stake disclosed; ownership is non-controlling and diluted by a larger share count.
The filing shows Utmost Group PLC holds 2,000,588 shares (0.0529%), with sole voting and dispositive power, which confirms clear internal control over these holdings despite the stake being immaterial to corporate control. The note that ownership percentage decreased because outstanding shares rose to 37,838,962 is important for context: absolute share count is unchanged while relative influence fell. For investors, this is a routine disclosure under Schedule 13G rather than an activist or control filing.
TL;DR: Governance implication minimal: Utmost reports sole authority on a very small, likely passive position.
The report classifies the filer as a foreign institution and documents subsidiary involvement